Future of hemophilia franchise?

Hemlibra taking all our market share, nothing in the pipeline, throwing Thrombate in our bag? If you’re you’re not putting resumes out, you are an idiot

 

Downsizing? Heard it already happened.

 

Likely to put you guys in the new NI division, no H. That's if you're not let go due to another "realignment." Might be a good idea to be looking around. No R&D outside of albutein and flebo and the last to market 20% that will only fly if priced right.

 

Welcome to Grifols, bringing you the best of the 70's and 80's today.

 

The future of Grifols' Hemophilia franchise is all behind it.

 

Fitusiran will be approved in 2020. That will be the death nail for all Grifols hemophilia drugs.

 

The Gri-Fills system will save the company. After all, it is a great success in Paraguay and Chile!

 

Very true. Our FVIII and FIV products will a distant memory.

 

This drug will take what's left of A8 and all of A9. The fat lady is clearing her throat...

 

Dionne Fabray will save us all.

 

You have a group of clowns running commercial. They have no clue what to do. They are all ex GSK and they are failing. Major re-structuring is desperately needed.

 

Hey Hey, Dionne Fabrey,
How did you get where you are today?
How many did you throw under the bus?
Please, please, please..tell us!

 

Hey Hey, Dionne Fabrey,
Why did you fire me?
How many others did you fire?
Please, please, please..take me back!
I can’t go back to flipping burgers,

 

https://www.foodnetwork.com/recipes/bobby-flay/perfect-burger-recipe-1957542

 

Mmmm...burgers

 

Account Res. 2014;21(6):389-400. doi: 10.1080/08989621.2014.882780.
Blood money: Bayer's inventory of HIV-contaminated blood products and third world hemophiliacs.
McHenry L1, Khoshnood M.
Author information

Abstract
This article presents an overlooked case of research misconduct and violations of basic principles of medical and business ethics. When Bayer's Cutter Laboratories realized that their blood products, Factor VIII and IX or antihemophiliac factor (AHF), were contaminated with human immunodeficiency virus (HIV), the financial investment in the product was considered too high to destroy the inventory. Cutter misrepresented the results of its own research and sold the contaminated AHF to overseas markets in Asia and Latin America without the precaution of heat treating the product recommended for eliminating the risk. As a consequence, hemophiliacs who infused the HIV-contaminated Factor VIII and IX tested positive for HIV and developed AIDS.

KEYWORDS:
AIDS; Bayer; Cutter Laboratories; Third World; antihemophiliac factor (AHF); hemophilia; hepatitis; human immunodeficiency virus (HIV)

PMID:

24785997

DOI:

10.1080/08989621.2014.882780
[Indexed for MEDLINE]

 

Hey, we suck less than Bayer! At least we didn't knowingly kill anyone.

 

I always figured Bayer sold the plasma biz because they knew the contamination chickens were coming home to roost.....